Clinical Trial Update: A Phase II Randomized Study Comparing the Efficacy and Safety of Targeted Therapy or Cancer Immunotherapy Versus Platinum-Based Chemotherapy in Patients With Cancer of Unknown Primary Site [Phase 2]

View source ↗

Summary

Phase II randomized study comparing targeted therapy or cancer immunotherapy against platinum-based chemotherapy in cancer of unknown primary site; results have…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer of Unknown Primary Site

Drugs mentioned

• Cancer immunotherapy (unspecified)
• Platinum-based chemotherapy (unspecified)
• Targeted therapy (unspecified)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Cancer of Unknown Primary Site | Phase 2 | Status: COMPLETED | Results posted: 2024-06-14